REG - Kromek Group PLC - Notice of AGM and Publication of Annual Report

KromekAnnouncement

03/10/2025 10:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251003:nRSC0081Ca&default-theme=true

RNS Number : 0081C  Kromek Group PLC  03 October 2025

3 October 2025

 

Kromek Group plc

("Kromek" or the "Group")

 

Notice of AGM and Publication of Annual Report

Directorate Changes

 

Kromek (AIM: KMK), a global detection company delivering best-in-class
solutions for the advanced imaging and CBRN detection markets, gives notice of
its Annual General Meeting ("AGM") and publication of annual report and
announces directorate changes.

 

Notice of AGM and publication of annual report

 

The Group's AGM will be held at 12.00pm on Monday 27 October 2025 in the
Kromek 'Biosecurity' Boardroom, Explorer 1 Building, North East Technology
Park (NETPark), Thomas Wright Way, Sedgefield, County Durham, TS21 3FF.

 

The notice of AGM and form of proxy, along with the Group's annual report and
accounts for the year ended 30 April 2025, are being posted today to those
shareholders who have requested paper communications and have been made
available on the Investor Relations section of the Group's website at
https://www.kromek.com/investor-relations/
(https://www.kromek.com/investor-relations/)

 

Directorate changes

 

Kromek announces that Lawrence Kinet and Jerel Whittingham, who have served as
Non-executive Directors of the Group since 2013, will be retiring from the
Board at the conclusion of the AGM. The Group also announces the appointment
of Matthew ("Matt") Boyle as a Non-executive Director of the Group with effect
from the conclusion of the AGM. He will also assume the role of Chair of the
Remuneration Committee.

 

Matt Boyle OBE FREng brings a wealth of industrial experience from having
worked for, and grown, engineering companies for more than 30 years. In
particular, he joined NASDAQ-listed Sevcon Inc in 1996 as Chief Operating
Officer before becoming President & Chief Executive Officer a year later,
a position he maintained until the sale of the business to BorgWarner in 2017.
During this time, Gateshead-based Sevcon was transformed from a low-growth
industrial company to a high-growth electrification company, expanding into
new sectors and establishing a presence in eight countries worldwide. Since
then, Matt has served in several leadership roles within major
electrification-focused businesses and organisations, including establishing
his own company, Collingwood Solutions, in 2018 that he sold two years later
for £6m and being a Special Adviser to the National Semiconductor Centre of
the UK Government's Department for Science, Innovation and Technology.

 

Currently, Matt holds a number of positions, including being Director of
Electrification at the National Manufacturing Institute Scotland where he has
established the National Advanced Semiconductor Packaging and Integration
Centre, a Professor of Practice at the University of Strathclyde, a Visiting
Professor of Engineering at Newcastle University and Chair of the North East
Automotive Alliance. He is also a trustee of Common Room of the Great North
and Azure Charitable Foundation.

 

Matt is a Fellow of the Royal Academy of Engineering and was awarded an OBE in
the 2018 New Years' Honours list for services to engineering and skills.

 

Rakesh Sharma, Chairman of Kromek, said: "Firstly, on behalf of the Board I
would like to express our deep gratitude to Lawrence and Jerel for their
contribution and guidance over the last 12 years. Since joining Kromek at the
IPO, they have seen the business grow from a university spinout into the
leading global technology provider that it is today. We wish them the very
best for the future.

 

"We are also delighted to welcome Matt Boyle to the Board, who has a truly
distinguished career in business and engineering. Kromek today is at a clear
inflection point, and Matt's expertise and experience will be invaluable
addition as we execute on our strategy to deliver sustainable, profitable
growth."

 

 

 

 Kromek Group plc
 Arnab Basu, CEO                                                        +44 (0)1740 626 060

 Claire Burgess, CFO

 Cavendish Capital Markets Limited (Nominated Adviser and Broker)        
 Geoff Nash/Giles Balleny/Seamus Fricker - Corporate Finance            +44 (0)20 7220 0500

 Tim Redfern - ECM

 Michael Johnson - Sales

 Gracechurch Group (Financial PR)
 Harry Chathli/Claire Norbury                                           +44 (0)20 4582 3500

 

Kromek Group plc

 

Kromek Group plc is a leading developer of radiation detection and
bio-detection technology solutions for the advanced imaging and CBRN detection
segments. Headquartered in County Durham, UK, Kromek has manufacturing
operations in the UK and US, delivering on the vision of enhancing the quality
of life through innovative detection technology solutions.

 

The advanced imaging segment comprises the medical (including CT and SPECT),
security and industrial markets. Kromek provides its OEM customers with
detector components, based on its core cadmium zinc telluride (CZT) platform,
to enable better detection of diseases such as cancer and Alzheimer's,
contamination in industrial manufacture and explosives in aviation
settings.

 

 In CBRN detection, the Group provides nuclear radiation detection solutions
to the global homeland defence and security market. Kromek's compact,
handheld, high-performance radiation detectors, based on advanced
scintillation and solid-state readout technology, are primarily used to
protect critical infrastructure, events, personnel and urban environments from
the threat of 'dirty bombs'.

 

The Group is also developing bio-security solutions in the CBRN detection
segment. These consist of fully automated and autonomous systems to detect a
wide range of airborne pathogens.

 

Kromek is listed on AIM, a market of the London Stock Exchange, under the
trading symbol 'KMK'.

 

Regulatory Disclosures:

The following information regarding the appointment of Matthew Boyle, aged 63,
is disclosed under Schedule 2(g) of the AIM Rules for Companies:

 Current directorships:                                        The Azure Charitable Foundation

                                                               Common Room Trading Limited

                                                               The Common Room Of The Great North Limited

                                                               The North East Automotive Alliance Limited

 Historic directorships and partnerships in previous 5 years:  PEMD Innovations Ltd

                                                               Cosworth Group Holdings Limited

                                                               Turntide Drives Limited

                                                               Collingwood Solutions Limited
                                                               Diocese Of Hexham And Newcastle
                                                               Avid Innovation Limited
                                                               Avid Technology Group Limited
                                                               Avid Technology Limited
                                                               Avid Electric Vehicles Limited
                                                               Avid Vehicles (projects) Limited
                                                               Turntide Transport Limited

 

Matthew Boyle holds no shares or share options in Kromek.

There are no further disclosures required under Schedule 2(g) of the AIM Rules
for Companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAFSDSUDEISESS